Drug Approval | March 05, 2025
Unichem Laboratories receives 4 observations from USFDA for Pithampur API facility
The company will provide the necessary response on these observations to USFDA within stipulated 15 days
The company will provide the necessary response on these observations to USFDA within stipulated 15 days
Zydus will carry out early-stage development, animal immunogenicity studies and regulatory preclinical toxicology studies for this combination vaccine
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
Collaborates with VisionSpring to conduct eye check-up camps for underprivileged children
The Alathur facility specializes in the production of Cephalosporin antibiotics
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
IMCD India’s innovative formulations bring the Skinification trend to life with cutting-edge solutions across beauty and personal care
This rating reflects Lupin's leadership in environmental transparency and performance
Vaccine helps protect against five common disease-causing serogroups of Neisseria meningitidis (A, B, C, W and Y)
The safety profile of Opdualag observed in this analysis was consistent with the known profiles of nivolumab and relatlimab
Subscribe To Our Newsletter & Stay Updated
